Avenue Therapeutics Total Risk Alpha
| ATXI Stock | | | USD 0.29 0.06 26.09% |
This module presents the Total Risk Alpha indicator for Avenue Therapeutics using available market inputs. The indicator computation uses normalized market activity data. Avenue Therapeutics has a market cap of 862.65 K, current ratio of 2.47. See
Trending Equities for portfolio-level analysis. Avenue Therapeutics can be tracked within a custom portfolio for ongoing monitoring. Each holding is sized according to the methodology applied during portfolio construction. Broader economic conditions can influence Avenue Therapeutics's company valuation — related indicators include
signals in services.
Avenue Therapeutics has current Total Risk Alpha of 1.7. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 1.7 | |
| ER[a] | = | Expected return on investing in Avenue Therapeutics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Avenue Therapeutics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Avenue Therapeutics places
second for total risk alpha among direct rivals. It is currently under evaluation for maximum drawdown among direct rivals recording roughly
72.20 in Maximum Drawdown for every unit of Total Risk Alpha. Maximum Drawdown outpaces Total Risk Alpha by
72.20 times for Avenue Therapeutics
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Avenue Therapeutics to Peers
Other Technical Indicators